Wille Finance

SwissComply AG is a company based in Zürich, Switzerland, that specializes in providing digital wealth management solutions tailored for independent wealth and asset managers, family offices, and banks. Established in 2014, SwissComply offers a modular assistance system designed to address the challenges faced by asset managers today and in the future. Its services encompass compliance and risk management, information technology, and operational support, allowing clients to optimize their processes, enhance competitiveness, reduce costs, and explore new development opportunities. The company aims to deliver a holistic and cost-effective solution that combines specialized know-how and advanced information technology to meet the evolving needs of its clientele.

Storebox is the first fully digitized self-storage solution in Europe, with more than 290 locations in Austria, Germany, Switzerland, Luxembourg, Belgium and Netherlands. The company offers storage spaces for private and business purposes, which are automatically accessible at any time. With the successful and awarded franchise system, Storebox manages to grow and will continue to expand within Europe. As a logistics partner Storebox helps to optimize last-mile logistics processes. Therefore it offers a wide range of customizable logistics solutions for business customers. There are two trends that are significant for Storebox, on the one hand urbanization and on the other hand the boom in e-commerce. Due to the growing e-commerce there are more and more empty retail spaces. Storebox has set itself the task of taking over these and transforming them into fully automated self-storage facilities. Due to increasing urbanization and the resulting downsizing of living space, it also requires more storage options. Urban development is also looking to micro hubs to enable rapid deliveries. These developments will continue and the network of storage and logistics solutions will have to become even denser. Our vision at Storeboxis clear: we shape logistics of tomorrow. To this end, we are eagerly pursuing our mission to grow into the largest and most innovative urban logistics network in Europe.

Kemiex is a Zurich-based online B2B trading platform that connects buyers and sellers of pharmaceutical ingredients and nutrition raw materials, providing market information, purchasing and sales services for active pharmaceutical ingredients, additives and excipients as well as raw materials used in human and animal nutrition and health. The platform serves pharmaceutical, veterinary, food and feed industries, facilitates global trading by linking buyers, sellers and traders, and aims to reduce transaction lead times while maintaining client control over trading activities.

Araris Biotech AG is a biotechnology start-up based in Zurich, Switzerland, founded in 2019. The company specializes in developing antibody-drug conjugate (ADC) linker technology aimed at enhancing chemotherapy by delivering chemotherapeutic agents directly to targeted antibodies. This innovative platform allows for the rapid production of high-quality ADCs without the need for extensive engineering of antibodies or cell lines, enabling the use of readily available antibodies. The site-specific conjugation process facilitates swift manufacturing and reliable quality control, supporting the creation of safe and potent drugs for various diseases. Araris Biotech's technology is protected by two patents, underscoring its commitment to advancing cancer treatment through improved safety and tolerability for patients.

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

Storebox is the first fully digitized self-storage solution in Europe, with more than 290 locations in Austria, Germany, Switzerland, Luxembourg, Belgium and Netherlands. The company offers storage spaces for private and business purposes, which are automatically accessible at any time. With the successful and awarded franchise system, Storebox manages to grow and will continue to expand within Europe. As a logistics partner Storebox helps to optimize last-mile logistics processes. Therefore it offers a wide range of customizable logistics solutions for business customers. There are two trends that are significant for Storebox, on the one hand urbanization and on the other hand the boom in e-commerce. Due to the growing e-commerce there are more and more empty retail spaces. Storebox has set itself the task of taking over these and transforming them into fully automated self-storage facilities. Due to increasing urbanization and the resulting downsizing of living space, it also requires more storage options. Urban development is also looking to micro hubs to enable rapid deliveries. These developments will continue and the network of storage and logistics solutions will have to become even denser. Our vision at Storeboxis clear: we shape logistics of tomorrow. To this end, we are eagerly pursuing our mission to grow into the largest and most innovative urban logistics network in Europe.

T3 Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, founded in 2015. The company focuses on the research and development of innovative bacteria-based therapies aimed at treating cancer patients. T3 Pharmaceuticals is committed to addressing the significant unmet need for novel cancer treatments by leveraging its proprietary protein delivery platform, which utilizes the bacterial type III secretion system. This approach enables the development of highly specific and efficient immuno-oncology therapies designed to target solid tumors. Through its work, T3 Pharmaceuticals aims to enhance the quality of life for cancer patients and improve treatment outcomes.